Perseus Proteomics (TSE:4882) Buyback Yield %: -19.76 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4882 Perseus Proteomics Inc TSE:4882
57 GF Score
Price 円149.00
GF Value 円439.87
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Perseus Proteomics Buyback Yield %?

Perseus Proteomics TSE:4882 -5.70% 57 Buyback Yield % is -19.76 as of Jul. 19, 2026. GuruFocus rates TSE:4882 with a GF Score™ of 57/100 and a GF Value™ of 円439.87 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 291 Drug Manufacturers companies, Perseus Proteomics ranks worse than 88.32% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Perseus Proteomics's current buyback yield was -19.76%.

Perseus Proteomics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Perseus Proteomics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perseus Proteomics Buyback Yield % Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only -54.22 0.00 -1.58 -8.55 -13.38

Perseus Proteomics Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.58 -11.36 -8.55 -0.07 -13.38

TSE:4882 vs LLY, JNJ, ABBV: Buyback Yield % Comparison

For the Drug Manufacturers - General subindustry, Perseus Proteomics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perseus Proteomics Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's Buyback Yield % falls into.


TSE:4882
57GF Score
Perseus Proteomics Inc TSE:4882
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perseus Proteomics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Perseus Proteomics's Buyback Yield for the fiscal year that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.106 + 500.5) / 3740
=-13.38%

Perseus Proteomics's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.106 + 500.5) / 3740
=-13.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -19.76 mean?
Perseus Proteomics (TSE:4882) has a Buyback Yield % of -19.76 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Perseus Proteomics and its competitors. According to the industry distribution chart, Perseus Proteomics ranks #257 out of 291 companies in the Drug Manufacturers industry, placing it in the top 88.3%.
Is Perseus Proteomics' Buyback Yield % too high?
Perseus Proteomics' current Buyback Yield % is -19.76. Based on the distribution chart, Perseus Proteomics ranks #257 out of 291 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Perseus Proteomics has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Perseus Proteomics' Buyback Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Perseus Proteomics ranks #257 out of 291 companies for Buyback Yield %. This places Perseus Proteomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Perseus Proteomics and its competitors. Perseus Proteomics's current Buyback Yield % is -19.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perseus Proteomics stock overvalued right now?
Based on GuruFocus' analysis, Perseus Proteomics (TSE:4882) is currently considered Significantly Undervalued. The stock's GF Value™ is 円439.87, compared to a current price of 円149.00 — trading 66.1% below its estimated fair value. The current Buyback Yield % is -19.76. Perseus Proteomics' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Perseus Proteomics (TSE:4882), the current Buyback Yield % is -19.76 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perseus Proteomics (TSE:4882) Overvalued in 2026?

Based on GuruFocus' analysis, Perseus Proteomics stock appears to be undervalued. The current stock price of 円149.00 is trading 66.1% below its estimated GF Value™ of 円439.87. GuruFocus considers Perseus Proteomics to be Significantly Undervalued.

Key valuation signals for TSE:4882:

  • Buyback Yield %: -19.76
  • GF Value™: 円439.87 vs. price of 円149.00 (66.1% below fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the TSE:4882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perseus Proteomics Business Description

Address 30-1 Hakozakicho, Nihonbashi, Chuo-ku, AiNihombashi EAST 3rd floor, Tokyo, JPN, 103-0015
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody-based therapeutics and diagnostic drugs to cure cancer and other diseases. The Company operates in a single segment, the pharmaceutical business.
57GF Score

Get the complete analysis for TSE:4882

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円149.00
Price
円439.87
GF Value